LONDON, March 7, 2023 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative diagnostics company focused on the prevention, detection, and diagnosis of ...
On March 2, BGI’s Multiplex Real-time Fluorescent RT-PCR Kit for Detecting SARS-CoV-2, Influenza A Virus and Influenza B Virus obtained market access qualification to enter the Australian Register of ...
In a recent study posted to the medRxiv* server, researchers in Germany and Switzerland evaluated 11 commercial reverse transcription-polymerase chain reaction (RT-PCR) kits (A to L) for Monkeypox ...
Wednesday, Virax Biolabs Group Limited (NASDAQ:VRAX) entered into a distribution agreement with a supplier of (RT) PCR Mpox virus detection kits to commercialize them in some European and Gulf ...
Virax Biolabs Group Ltd (NASDAQ:VRAX) shares are trading higher on abnormally high volume Tuesday after the company announced an agreement for the distribution of an Avian Influenza A Virus (AIV) real ...
Respiratory syncytial virus (RSV) was detected easiest when using reverse transcription polymerase chain reaction (RT-PCR) tests in a pediatric population. Reverse transcription polymerase chain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results